These results integrate peripheral and central mechanisms to explain how D2 receptor hypofunction increases vulnerability to obesity and suggest that targeting insulin–dopamine interactions may offer sex‐specific strategies for prevention or treatment. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.